Table 3 Calcemia course and etiological investigations of patients with hypercalcemia
From: Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients
All (n = 131) | |
|---|---|
Calcemia | |
Calcemia at day 1 (mg/dL) | 14.5[13.2;16.3] |
Corrected calcemia at day 1 (mg/dL) | 15.6 [14;17.2] |
Ionized calcemia at day 1 (mEq/L) | 3.5 [3.1;3.9] |
Minimal etiological screening | 86 (65.6) |
PTH: patients tested, n (%) | 84 (64.1) |
PTH median level (ng/mL) | 11 [4.9; 47.5] |
High PTH, n (%) | 16 (19) |
Low or abnormally normal PTH, n (%) | 68 (81) |
PTH-rp: patients tested, n (%) | 17 (13) |
High PTH-rp, n (%) | 3 (2.3) |
Active Vitamin D (1,25-dihydroxyvitamin D): patients tested, n (%) | 52 (39.7) |
Active Vitamin D (1,25-dihydroxyvitamin D) (pg/mL) | 16 [6.9; 28.3] |
High active Vitamin D (1,25-dihydroxyvitamin D) levels, n (%) | 21 (16) |
Vitamin D (25-dihydroxyvitamin D): patients tested, n (%) | 65 (49.6) |
Vitamin D (25-dihydroxyvitamin D) (ng/mL) | 9.3 [5.8; 13.6] |
High Vitamin D (25-dihydroxyvitamin D) levels, n (%) | 2 (1.5) |
Phosphatemia at admission (mg/dL) | 3.5 [2.6; 4.9] |